Skip to content

A randomized controlled trial of Chinese massage (Tuina) on constipation after posterior approach lumbar interbody fusion

A randomized controlled trial of Chinese massage (Tuina) on constipation after posterior approach lumbar interbody fusion

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400083426
Enrollment
Unknown
Registered
2024-04-24
Start date
2024-04-25
Completion date
Unknown
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative constipation

Interventions

Tuina Group:Step one: Tai Chi Large Circle: Step two: Tai Chi Small Circle: Step three: "-----" Track Abdominal Push Step four: "M" Track Abdominal Exercise: Step five: "*" Track Abdominal Rub: St
Control Group:Patients in the control group will receive a conventional pharmacological treatment regimen of one Lactulose Oral Solution 10mL TID (10mL per bottle, Fresenius Kabi Austria GmbH, Beijing

Sponsors

Zhejiang province hospital of Chinese medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: In order to be included in this trial, participants have tobe: (i) Patients who meet the indications for TLIF surgery, including simultaneous fulfillment of the following conditions:?Intervertebral disc protrusion, extrusion, or incomplete fusion leading to symptoms such as nerve root compression or spinal canal stenosis;?Presence of spinal instability causing persistent lower back pain or neurological symptoms;?Ineffectiveness of long-term non-surgical treatment;?Patient's willingness to undergo TLIF surgery. Patients in our hospital who have undergone the first single-level or two-level TLIF surgery and have not had a bowel movement within 3 days after surgery; (ii) between 20 to 75-year-old; (iii) free of immune dysfunction, genetic disorders,or severe cardiovascular diseases; (iv) free from any kind of hormonal or antirheumatic drugs for the two months prior to inclusion;(v) free from allergies to Hypoammoniants and laxatives; and(vi) able to understand and accept all trial procedures and cooperate with clinical physicians’ practices.

Exclusion criteria

Exclusion criteria: Participants with any one of the following conditions will be excluded from this trial: (i) pregnancy; (ii) severe heart, liver, or renal dysfunction; (iii) tumor; (iv) any hematological, respiratory, or cardiovascular disease; (v)any psychiatric disorder; (vi) any disorders that may confound the assessment of tuina efficacy, such as paraplegia or ileus, and (vii) have received tuina therapy for constipation in the past three months.

Design outcomes

Primary

MeasureTime frame
defecate time;Patient Assessment of Constipation Symptoms;

Countries

China

Contacts

Public ContactTaotao Xu

Zhejiang province hospital of Chinese medicine

xut@zcmu.edu.cn+86 151 5819 0125

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026